eujobs.coEU jobs in brussels
Post a JobHeadhunter

Inserm Transfert

Acronym: IT

General Information

Identification Code: 190044226228-01
Website: http://www.inserm-transfert.fr
Entity Form: Ltd
Registration Category: Companies & groups
Registration Date: 3/22/2017
Last Update: 4/3/2024

Mission & Interests

Goals: Private subsidiary of Inserm, Inserm Transfert manages every aspect of the promotion and transfer of knowledge obtained by Inserm’s research laboratories to industry, thereby helping to promote health innovation. Inserm Transfert focus on adding value and minimizing risk for innovative projects at pre-industrial stage, bridging discovery and clinical research. We put emphasis on identifying high-potential projects, implementing appropriate proof of concept and IP strategies, and setting up win-win/mutually beneficial industrial partnerships.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
  • Banking and financial services
  • Competition
  • Consumers
  • Institutional affairs
  • Public health
  • Regional policy
  • Research and innovation
Levels of Interest:
  • global

Activities

Main EU Legislative Proposals: EU legislatives proposals or policies pertaining to - Pharmaceutical regulation and medicinal product marketing authorisation, - Research and innovation, - Public health (both human and animal and digital health data)
Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: 10 rue d'Oradour-sur-Glane
Post Code: 75015
City: Paris
Country: FRANCE
Phone:
Indic Phone: 33
Phone Number: 155030100

EU Office

Address: 10 rue d'Oradour-sur-Glane
Post Code: 75015
City: Paris
Country: FRANCE
Phone:
Indic Phone: 33
Phone Number: 155030100

Financial Data

Closed Year:
Start Date:
End Date:
Funding Sources:
    Contributions:
      Total Budget: 0
      Grants:
      • Source: Cardiateam Project IMI2-2017-13-01
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 44
      • Source: CARE Project IMI2 call 21 coronavirus
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 45
      • Source: CCH Vaccine H2020 SC1-PM-06-2016
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 46
      • Source: FAIR H2020-SC1-BHC-14-2019
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 47
      • Source: IP-Cure-B Project H2020-SC1-BHC-14-2019
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 48
      • Source: JPsustaiND Project H2020-HCO-2015
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 49
      • Source: MAD-CoV 2 Project IMI2-2020-21-01
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 50
      • Source: MEDIT-AGEING Project H2020-PHC-2015
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 51
      • Source: miniNO Project SC1-BHC-01-2019
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 52
      • Source: MIROCALS Project H2020-PHC-2014-two-stage
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 53
      • Source: R-LiNK Project SC1-PM-02-2017
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 54
      • Source: THERALYMPH Project H2020 SC1-BHC-07-2019
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 55
      • Source: VHFMODRAD Project IMI2-2015-08
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 56
      • Source: EJP-RD Project SC1-BHC-04-2018
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 57
      • Source: RITA-MI2 Project H2020-SC1-BHC-2018-2020
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 58
      • Source: CBIG-SCREEN Project H2020-SC1-BHC-2018-2020
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 59
      • Source: BE READY Project HORIZON-HLTH-2021-DISEASE-04
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 60
      • Source: MPX-RESPONSE Project HORIZON-HLTH-2022-MPX-14-01
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 61
      • Source: HT Advance Project HORIZON-HLTH-2022-TOOL-11-01
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 62
      • Source: CARE IN HEALTH Project HORIZON-HLTH-2022-STAYHLTH-02-01
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 63
      • Source: OBELISK Project HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 64
      • Source: MITI2 Project HORIZON-HLTH-2022-DISEASE-06-02-two-stage
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 65
      • Source: ARTiDe Project HORIZON-HLTH-2022-DISEASE-06-two-stage
        Amount: 0
        Currency: €
        _id:
        Buffer:
        0: 104
        1: 64
        2: 60
        3: 213
        4: 158
        5: 212
        6: 182
        7: 32
        8: 86
        9: 89
        10: 253
        11: 66
      Current Year:
      Grants:
        Complementary Information: EU grants that contribute to the operating costs - We have a department dedicated to project management of EC projects. This department is made up of 25 people namely- Collaborative Research Funding - entirely dedicated since 2003 to support researchers in handling project management and reporting to European Commission. During the most recent closed financial year (2023) our company was a full partner of 34 EU funding projects and recevied prepayment for 23 projects.

        Membership Information

        Members10 Percent: 2
        Members25 Percent: 1
        Members: 3
        Members F T E: 0.44999998807907104
        Info Members: Our involvement begins (with INSERM), by raising topics that can be subject of a topic in the various EU work programs thanks to the French representative at the EU committee program, with the contribution of Catherine Clusel - Director of the Collaborative Research funding department (25%) Our CEO Pascale Augé and Sandrine Ayuso - chief of staff - (10% each) act as Inserm Transfert representatives at national, european and international level.

        Structure

        Structure Type: Structure
        Is Member Of: Inserm Transfert is the private subsidiary of the National Institut of Health and Medical research (INSERM) http://www.inserm.fr/inserm-transfert (https://www.inserm-transfert.fr/inserm-transfert-en/our-mission-and-successes/)
        Organisation Members: Inserm Transfert is a member of the - Reseau C.U.R.I.E https://www.curie.asso.fr/reseau-curie/qui-sommes-nous/administrateurs - Association France Biotech https://france-biotech.fr/annuaire/?_annuaire=adherents&_company_name=Inserm%20Transfert - Pascale Augé our CEO is a membre of the network AUTM-Association of University Technology Managers https://autm.net/

        Current Job Opportunities

        Senior Policy Advisor at Inserm Transfert

        Inserm Transfert

        mid-levelBrussels, BelgiumFull-time-time
        View DetailsApply Now →
        Posted: 9/23/2025

        Association Assistant

        SEC Newgate EU

        juniorBrussels, Belgiumfull-time
        View Details
        Posted: 10/1/2025

        Product & Corporate Communications Manager

        Mistral AI

        mid-levelBrussels, Francefull-time
        View DetailsApply Now →
        Posted: 8/21/2025